NASDAQ:RNW

ReNew Energy Global Plc (NASDAQ: RNW) Shines with Strong Q4 Financial Results and Renewable Energy Growth

Font: Financial Modeling Prep  • May 18, 2026

Market Chart
  • ReNew Energy Global Plc (NASDAQ: RNW) demonstrated robust financial health, exceeding market expectations for both revenue and earnings per share in its latest quarter.
  • The company continues to expand its renewable energy footprint, with significant growth in operational and commissioned capacity, solidifying its position in the clean energy sector.
  • Strategic initiatives, including manufacturing expansion and a competitive P/E ratio, highlight ReNew's potential for sustained growth and investor value.

ReNew Energy Global Plc is a major player in the renewable energy sector. The company develops, builds, owns, and operates utility-scale wind, solar, and hydro energy projects. As of March 2026, its operational portfolio has grown to approximately 20 gigawatts (GWs), showing significant scale in its clean energy activities.

On May 18, 2026, ReNew Energy Global Plc announced its fourth-quarter financial results. The company reported strong revenue of $423.16 million, which comfortably surpassed the market's consensus estimate of $307.73 million. This performance marks the fourth consecutive quarter that the company has exceeded revenue expectations, indicating consistent top-line growth.

Regarding its profitability, the company's earnings per share (EPS) also beat expectations. As highlighted by Zacks, ReNew reported quarterly earnings of $0.02 per share. This figure was a significant surprise, as it surpassed the consensus estimate which predicted a loss of $0.21 per share. This is the third time in the last four quarters that ReNew has topped EPS estimates.

Looking at its valuation, ReNew Energy Global Plc has a Price-to-Earnings (P/E) ratio of 16.17. This metric suggests investors are paying about $16 for every dollar of the company's annual earnings. The company's Debt-to-Equity ratio is 6.29, which shows how much debt it uses to finance its assets compared to the value owned by shareholders.

Operationally, ReNew continues to expand its capacity. Its commissioned capacity, which represents projects that are complete and generating power, increased by 16.6% from the previous year to about 12.6 GWs. The company is also growing its manufacturing arm, with plans to add 4 GW of solar cell capacity by December 2026.

Market Overview
VRAX
Virax Biolabs Group Limited
$0.24
53.09%
WGRX
Wellgistics Health, Inc.
$0.17
108.38%
AIM
AIM ImmunoTech Inc.
$0.41
61.26%
SBFM
Sunshine Biopharma, Inc.
$0.51
79.51%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$9.95
7.80%
TZA
Direxion Daily Small Cap Bear 3X ETF
$5.05
1.81%
PMI
Picard Medical, Inc.
$0.17
7.06%
GOVX
GeoVax Labs, Inc.
$2.21
79.67%
NXXT
NextNRG Inc.
$0.41
46.22%
CREG
Smart Powerr Corp.
$0.62
30.59%